Adheris Health Ltd (ASX: AHE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Adheris Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$12.75 million
P/E Ratio
107.69
Dividend Yield
0.00%
Shares Outstanding
637.68 million
Earnings per share
-0.103
Dividend per share
N/A
Year To Date Return
N/A
Earnings Yield
0.93%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Adheris Health Ltd (ASX: AHE)
Latest News
Share Gainers
Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday
Share Market News
MedAdvisor Ltd (ASX:MDR) share price halted ahead of transformational $49 million acquisition
Speculative
3 small cap ASX healthcare shares to watch closely in the 2020s
Share Market News
Add these 3 ASX medical technology companies to your watch list
Speculative
3 exciting small cap ASX healthcare shares to watch
Speculative
3 exciting small cap ASX shares to watch very closely
Speculative
3 exciting small cap ASX healthcare shares to watch
Speculative
3 exciting ASX healthcare shares to watch in the 2020s
⏸️ ASX Shares
3 small cap ASX healthcare shares with enormous potential
Coronavirus News
Coronavirus: This ASX tech share is rocketing higher after telehealth launch
Coronavirus News
Why this ASX medical tech share is up 22% today
Share Market News
Why this ASX medical technology share surged 43% higher today
AHE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Adheris Health Ltd
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. It operates through the following segments: MedAdvisor and Corporate. The MedAdvisor segment includes medication management and adherence platform. The Corporate segment comprises of the company's function associated with being an ASX listed company. MedAdvisor was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
AHE Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 24 Apr 2026 | $0.02 | $0.00 | 0.00% | 116,401 | $0.02 | $0.02 | $0.02 |
| 23 Apr 2026 | $0.02 | $0.00 | 0.00% | 264,454 | $0.02 | $0.02 | $0.02 |
| 22 Apr 2026 | $0.02 | $0.00 | 0.00% | 455,251 | $0.02 | $0.02 | $0.02 |
| 21 Apr 2026 | $0.02 | $0.00 | 0.00% | 269,799 | $0.02 | $0.02 | $0.02 |
| 20 Apr 2026 | $0.02 | $0.00 | 0.00% | 9,755 | $0.02 | $0.02 | $0.02 |
| 17 Apr 2026 | $0.02 | $0.00 | 0.00% | 180,428 | $0.02 | $0.02 | $0.02 |
| 16 Apr 2026 | $0.02 | $0.00 | 0.00% | 51,639 | $0.02 | $0.02 | $0.02 |
| 15 Apr 2026 | $0.02 | $0.00 | 0.00% | 479,172 | $0.02 | $0.02 | $0.02 |
| 14 Apr 2026 | $0.02 | $0.00 | 0.00% | 100,000 | $0.02 | $0.02 | $0.02 |
| 13 Apr 2026 | $0.02 | $0.00 | 0.00% | 290,126 | $0.02 | $0.02 | $0.02 |
| 10 Apr 2026 | $0.02 | $0.00 | 0.00% | 1,373,469 | $0.02 | $0.02 | $0.02 |
| 09 Apr 2026 | $0.02 | $0.00 | 0.00% | 248,550 | $0.02 | $0.02 | $0.02 |
| 08 Apr 2026 | $0.02 | $0.00 | 0.00% | 76,255 | $0.02 | $0.02 | $0.02 |
| 07 Apr 2026 | $0.02 | $0.00 | 0.00% | 20,870 | $0.02 | $0.02 | $0.02 |
| 02 Apr 2026 | $0.02 | $0.00 | 0.00% | 73,292 | $0.02 | $0.02 | $0.02 |
| 01 Apr 2026 | $0.02 | $0.00 | 0.00% | 25,250 | $0.02 | $0.02 | $0.02 |
| 31 Mar 2026 | $0.02 | $0.00 | 0.00% | 170,224 | $0.02 | $0.02 | $0.02 |
| 30 Mar 2026 | $0.02 | $0.00 | 0.00% | 193,816 | $0.02 | $0.02 | $0.02 |
| 27 Mar 2026 | $0.02 | $0.00 | 0.00% | 264,604 | $0.02 | $0.02 | $0.02 |
| 26 Mar 2026 | $0.02 | $0.00 | 0.00% | 2,500 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 10 Apr 2026 | John Ciccio | Issued | 30,000,000 | $540,000 |
Issue of options.
|
| 09 Mar 2026 | Lucas Merrow | Buy | 695,000 | $15,116 |
On-market trade. Average price
|
| 03 Mar 2026 | Lucas Merrow | Buy | 890,000 | $19,580 |
On-market trade. Average price
|
| 02 Mar 2026 | Catherine (Kate) Hill | Buy | 1,500,000 | $30,000 |
On-market trade. Average price
|
| 06 Nov 2025 | Lucas Merrow | Issued | 500,000 | $50,000 |
Placement.
|
| 06 Nov 2025 | Catherine (Kate) Hill | Issued | 500,000 | $50,000 |
Placement.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Catherine (Kate) Jane Hill | Non-Executive DirectorInterim Chairman | May 2023 |
Ms Hill is an experienced auditor and business advisor with over 30 years of experience of working with privately owned companies across a range of business issues. She is an experienced director of small- to mid-cap companies listed on global exchanges, with a record in creating change involving new business models, new markets and new technologies. She is a Member of People Committee and Chair of Risk Committee.
|
| Mr Sean Slattery | Chief Financial OfficerExecutive Director | Jul 2025 |
Mr Slattery is a finance executive who has worked with med-tech ASX listed companies with US operations, recently Rhinomed (ASX:RNO) ahead of its recent sale.
|
| Mr Lucas Merrow | Non-Executive Director | Aug 2021 |
Mr Merrow co-founded and served as the CEO of Eliza Corporation- health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the COO of Adheris Health, a firm in prescription adherence and patient education programs in the United States. He is a Member of People Committee
|
| Mr John Ciccio | Chief Executive OfficerManaging Director | Nov 2025 |
--
|
| Mr Lee Tamplin | Company Secretary | Apr 2026 |
-
|
| Ancila Desai | Chief Financial Officer |
-
|
|
| Lee Tamplin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 106,641,679 | 17.07% |
| Guild Group Holdings Limited | 94,905,130 | 15.19% |
| J P Morgan Nominees Australia Pty Limited | 59,815,291 | 9.57% |
| Ebos Ph Pty Ltd | 53,986,823 | 8.64% |
| Cotiviti Inc | 43,999,999 | 7.04% |
| Citicorp Nominees Pty Limited | 31,610,031 | 5.06% |
| Bond Street Custodians Limited (Salter D79836 A/C) | 27,550,000 | 4.41% |
| BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) | 16,278,900 | 2.61% |
| Indcorp Consulting Group Pty Limited (Superannuation Fund A/C) | 7,145,000 | 1.14% |
| Kojent Pty Ltd (Kojent A/C) | 6,846,956 | 1.10% |
| Romida Enterprises Pty Ltd (Romida Family A/C) | 5,642,935 | 0.90% |
| Gread Management Pty Limited (The A G & R R Family A/C) | 5,344,283 | 0.86% |
| Tagdime Pty Ltd (Ian M Davison P/L S/F A/C) | 4,331,854 | 0.69% |
| Dr Christopher Harold Benton | 4,215,000 | 0.67% |
| Provare Pty Ltd (Provare Investment A/C) | 3,743,419 | 0.60% |
| Dmx Capital Partners Limited i | 2,500,000 | 0.40% |
| Dmx Capital Partners Limited | 2,434,351 | 0.39% |
| Celerity Investments Pty Limited | 2,348,978 | 0.38% |
| Hylec Controls Pty Ltd | 2,300,000 | 0.37% |
| Hylec Investments Pty Limited (Hylec Controls P/L S/F A/C) | 2,300,000 | 0.37% |
